Former FDA Chief Critiques HHS for Policy-Based Evidence Approach

Feb 8, 2026, 2:25 AM
Image for article Former FDA Chief Critiques HHS for Policy-Based Evidence Approach

Hover over text to view sources

Dr Robert M. Califf, the former Commissioner of the US Food and Drug Administration (FDA), has raised alarms about the current direction of the Department of Health and Human Services (HHS). He argues that HHS leadership is increasingly focused on "policy-based evidence" rather than adhering to the principles of "evidence-based policy." This shift, he contends, could have serious implications for public health and vaccine policy in the United States.
Califf's concerns were articulated in the context of recent statements by the new chair of the CDC's Advisory Panel on Vaccination Practices, Dr Kirk Milhoan. Milhoan suggested that the polio vaccine might no longer be necessary, prompting criticism from public health experts. This incident exemplifies a broader trend where individual observations and experiences are prioritized over rigorous scientific data. Califf emphasizes that such an approach can compromise the ethical foundation of public health and medicine.
The notion of prioritizing "individual autonomy" over public health is problematic, according to Califf. He argues that effective medical practice must balance individual experiences with robust, population-level data to make informed decisions about health interventions. For instance, while individual clinicians may observe immediate side effects of vaccinations, such as arm soreness or fever, the broader benefits—such as the prevention of disease outbreaks—can only be assessed through large-scale studies.
Historically, the FDA and CDC operated under a system that emphasized scientific rigor and transparency in policy-making. This involved public debates, independent evaluations, and a commitment to evidence-based practices that informed vaccine recommendations. However, Califf warns that the current administration seems to favor a model where evidence is selectively used to support predetermined policies, rather than allowing scientific inquiry to guide decisions.
The implications of this policy shift are far-reaching. Califf notes that no individual clinician can fully gauge the benefits of vaccines solely through personal experience. Instead, comprehensive, methodologically sound studies are essential to understand the risk-benefit ratio of vaccination programs. This is particularly crucial in preventing diseases like polio, which have historically posed significant public health threats.
Furthermore, Califf highlights a disturbing trend in recent dietary guidelines issued by HHS, which have been criticized for lacking scientific rigor and clarity. The removal of specific alcohol consumption guidelines illustrates a departure from evidence-based recommendations and raises concerns about the potential public health impact of such decisions.
Califf advocates for a restoration of a system where evidence is compiled transparently, allowing public input and scientific discourse to inform policy decisions. He argues that advisers should be selected based on their expertise rather than their alignment with political positions. This call for integrity in health policy echoes a growing sentiment among public health professionals who fear that political agendas may increasingly dictate health outcomes.
The challenges of maintaining public trust in health recommendations are compounded by the COVID-19 pandemic, which has exposed vulnerabilities in the FDA's credibility. Public skepticism regarding vaccine safety and efficacy has been fueled by perceived political interference in regulatory processes. Califf's stance underscores the need for HHS to prioritize scientific integrity and public health over political considerations, ensuring that health policies are grounded in solid evidence.
In conclusion, as the landscape of public health continues to evolve, the principles of evidence-based policy must remain at the forefront of decision-making. Dr Califf's critique serves as a reminder of the importance of scientific rigor and transparency in health policy, particularly in a time of heightened public scrutiny and mistrust. The stakes are high, as the future of public health depends on the integrity of the systems designed to protect it.

Related articles

SC Senator Proposes Bill to Eliminate Religious Exemptions for Measles Vaccine

South Carolina State Senator Margie Bright Matthews has introduced a bill to abolish religious exemptions for the measles vaccine, aiming to improve public health amid a significant outbreak in the state. The proposal has sparked debate, with critics arguing it infringes on religious freedoms.

Trust in CDC at Low Point Amid Vaccine Schedule Changes

A recent KFF Tracking Poll reveals a significant decline in public trust towards the CDC, with less than half of Americans expressing confidence in the agency's vaccine guidance. The poll highlights partisan divides regarding the newly revised childhood vaccination schedule, with many expressing concerns about its impact on children's health.

President Trump Launches TrumpRx to Make Medicines More Affordable

On February 5, President Donald Trump unveiled TrumpRx, a new initiative aimed at providing cost-effective medications to Americans. The program, set to launch in 2026, is expected to significantly reduce prices for popular GLP-1 weight loss medications, making them accessible to more individuals.

CT Health Commissioner Supports Pediatric Vaccine Guidelines Over CDC

Connecticut Health Commissioner Manisha Juthani has endorsed the American Academy of Pediatrics' vaccine recommendations, diverging from recent changes made by the CDC. This decision reflects a broader movement among several states to prioritize evidence-based vaccine policies amid federal uncertainties.

Oklahoma Lawmakers Must Embrace Evidence-Based Medicine

Oklahoma's legislative choices often undermine modern medicine, as seen in recent proposals that prioritize ideology over evidence. Lawmakers are called to support health initiatives grounded in science to improve public health outcomes and trust in medical professionals.